Peripheral intravenous (PIV) access is often considered a simple, low-risk procedure, when in fact:
Up to 90% of patients require a PIV during their hospital stay.¹
Up to 47% of CLABSIs occurred in patients with multiple lines- including PIVs.²
There are 165,000 potential PIV-related bloodstream infections per year in the US.³
Cost of treating PIV failure-related complications can add 7–20 hospital days with total costs reaching up to $2.3 billion in US ICUs alone each year.⁴
Find out just how widespread PIVC failure is in the six-study clinical evidence summary.
Get fast facts on PIVCs and learn about evidence-based best practice bundles for catheter insertion, maintenance and removal in this 12-page guide.
As your trusted partner in protecting patients, we share your goal of reducing the risk of PIV complications. And we want to do everything in our power to help you achieve it.
We believe there are three keys to reaching this goal: people, practice, and products. It’s an effort that requires exacting standards of care, a commitment from the care team to methodically adhere to those standards, and technology that adds an additional layer of protection.
Preventing bloodstream infections takes training and commitment. Learn more about 3M resources to help clinicians ensure proper protocols are followed for every patient, every time.
The 3M™ Peak™ Clinical Outcomes Program provides you with the resources and partnership you need to define and achieve the outcomes most important to you, your patients and your organization.
3M℠ Health Care Academy offers free, quality educational content in a flexible online format. Choose from more than 50 CE credit courses to support your professional development, including courses on bloodstream infection prevention.
Insights on skin, complications prevention and patient care.
The Infusion Nurses Society (INS) is a global authority on infusion therapy, setting stringent standards for practice. Every five years, INS releases updated, peer-reviewed standards that reflect the latest evidence to define and develop best practices for all clinical settings. 3M can help you stay up to date so you can help deliver better patient outcomes.
3M’s evidence-based antimicrobial product offerings protect against both extraluminal and intraluminal contamination of PIVs. When properly deployed, these antimicrobial solutions offer another line of defense against potential contamination.
Learn how to reduce the risk of peripheral IV complications at all access points and make peripherals a central focus of your IV care program.
Connect with a 3M Representative to receive a sample of the solutions that address peripheral IV needs.
Thank you for connecting with 3M! We’ll be in touch with you shortly.
An error has occurred while submitting. Please try again later...
1. Helm RE, Klausner JD, Klemperer JD, et al. Accepted but unacceptable: peripheral IV catheter failure. J Infus Nurs. 2015;38(3):189-203
2. DeVries M, Mancos P, Valentine MJ. Reducing bloodstream infection risk in central and peripheral intravenous lines: Initial data on passive intravenous connector disinfection. J Assoc Vasc Access. 2014;19(2):87-93
3. Hadaway L. Short peripheral intravenous catheters and infections. Journal of Infusion Nursing. 2012;35(4).
4. Helm RE, Klausner JD, Klemperer JD, Flint LM, Huang E. Accepted but unacceptable:
Peripheral IV catheter failure. J Infus Nurs. 2015;38(3):189-203